| Medicinal product name | Atazanavir Sandoz 300 mg hard capsules |
|---|---|
| Pharmaceutical form | Capsule, hard |
| Strength | 300 mg |
| Information from the MAH on shortages | No information on expected shortages |
| Legal status | Prescription (Pr.) |
| Package leaflet |  27-06-2023
|
| Summary of product characteristics | 27-06-2023
|
| ATC code | J05AE08 – Antivirals for systemic use |
| Information for Marketing authorisation holders | View |
Medicinal products (12)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30: 30 × 1 (300 mg) |
OPA/Al/PVC/Al unit-dose blister | 18-0163-01 |
 Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60: 2 × 30 × 1 (300 mg) |
OPA/Al/PVC/Al unit-dose blister | 18-0163-02 |
Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N90: 3 × 30 × 1 (300 mg) |
OPA/Al/PVC/Al unit-dose blister | 18-0163-03 |
Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N120: 4 × 30 × 1 (300 mg) |
OPA/Al/PVC/Al unit-dose blister | 18-0163-04 |
Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (300 mg) |
OPA/Al/PVC/Al blister | 18-0163-05 |
Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60: 2 × 30 (300 mg) |
OPA/Al/PVC/Al blister | 18-0163-06 |
Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N90: 3 × 30 (300 mg) |
OPA/Al/PVC/Al blister | 18-0163-07 |
Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N120: 4 × 30 (300 mg) |
OPA/Al/PVC/Al blister | 18-0163-08 |
Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (300 mg) |
HDPE bottle | 18-0163-09 |
Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60: 2 × 30 (300 mg) |
HDPE bottle | 18-0163-10 |
Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N90: 3 × 30 (300 mg) |
HDPE bottle | 18-0163-11 |
Labelling text Jun 15, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N120: 4 × 30 (300 mg) |
HDPE bottle | 18-0163-12 |
Labelling text Jun 15, 2021 |
Registration information
| Marketing authorisation No. | 18-0163 |
|---|---|
| Date of authorisation | Oct 31, 2018 |
| Marketing authorisation holder, country | Sandoz d.d., Slovenia |
